Adell Harriman & Carpenter Inc Amgen Inc Transaction History

Adell Harriman & Carpenter Inc

  • $1.38 Trillion
  • Q3 2024

A detailed history of Adell Harriman & Carpenter Inc transactions in Amgen Inc stock. As of the latest transaction made, Adell Harriman & Carpenter Inc holds 16,700 shares of AMGN stock, worth $4.68 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
16,700
Previous 17,245 3.16%
Holding current value
$4.68 Million
Previous $5.39 Billion 0.14%
% of portfolio
0.39%
Previous 0.42%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024
SELL
$309.38 - $337.38 $168,612 - $183,872
-545 Reduced 3.16%
16,700 $5.38 Billion
Q2 2024

Aug 01, 2024
SELL
$262.75 - $319.31 $53,863 - $65,458
-205 Reduced 1.17%
17,245 $5.39 Billion
Q1 2024

Apr 25, 2024
BUY
$268.87 - $324.56 $50,278 - $60,692
187 Added 1.08%
17,450 $4.96 Billion
Q4 2023

Feb 05, 2024
BUY
$255.7 - $288.46 $43,469 - $49,038
170 Added 0.99%
17,263 $4.97 Billion
Q3 2023

Nov 07, 2023
BUY
$218.65 - $271.46 $143,215 - $177,806
655 Added 3.98%
17,093 $4.59 Billion
Q2 2023

Aug 04, 2023
SELL
$214.27 - $253.37 $200,342 - $236,900
-935 Reduced 5.38%
16,438 $3.7 Billion
Q1 2023

May 03, 2023
SELL
$225.79 - $275.2 $230,757 - $281,254
-1,022 Reduced 5.56%
17,373 $4.2 Billion
Q4 2022

Feb 03, 2023
SELL
$229.03 - $291.01 $253,765 - $322,439
-1,108 Reduced 5.68%
18,395 $4.83 Billion
Q3 2022

Nov 03, 2022
SELL
$224.46 - $253.15 $123,453 - $139,232
-550 Reduced 2.74%
19,503 $4.4 Billion
Q2 2022

Aug 03, 2022
SELL
$230.71 - $256.74 $94,360 - $105,006
-409 Reduced 2.0%
20,053 $4.88 Million
Q1 2022

Apr 29, 2022
SELL
$219.27 - $242.57 $316,845 - $350,513
-1,445 Reduced 6.6%
20,462 $4.95 Million
Q4 2021

Feb 16, 2022
SELL
$198.88 - $227.6 $550,499 - $629,996
-2,768 Reduced 11.22%
21,907 $4.93 Million
Q3 2021

Nov 05, 2021
SELL
$212.27 - $248.7 $704,736 - $825,684
-3,320 Reduced 11.86%
24,675 $5.25 Million
Q2 2021

Aug 10, 2021
SELL
$233.58 - $259.14 $142,250 - $157,816
-609 Reduced 2.13%
27,995 $6.82 Million
Q1 2021

May 03, 2021
SELL
$221.91 - $258.6 $88,542 - $103,181
-399 Reduced 1.38%
28,604 $7.12 Million
Q4 2020

Feb 05, 2021
SELL
$216.38 - $257.67 $29,211 - $34,785
-135 Reduced 0.46%
29,003 $6.67 Million
Q3 2020

Nov 06, 2020
BUY
$234.65 - $260.95 $284,865 - $316,793
1,214 Added 4.35%
29,138 $7.41 Million
Q2 2020

Aug 13, 2020
BUY
$197.81 - $242.74 $30,660 - $37,624
155 Added 0.56%
27,924 $6.59 Million
Q1 2020

May 07, 2020
SELL
$182.24 - $241.7 $232,356 - $308,167
-1,275 Reduced 4.39%
27,769 $5.63 Million
Q4 2019

Feb 07, 2020
SELL
$189.21 - $243.2 $632,150 - $812,531
-3,341 Reduced 10.32%
29,044 $7 Million
Q3 2019

Nov 08, 2019
BUY
$174.11 - $208.62 $198,485 - $237,826
1,140 Added 3.65%
32,385 $6.27 Million
Q2 2019

Aug 07, 2019
SELL
$166.7 - $195.41 $58,511 - $68,588
-351 Reduced 1.11%
31,245 $0
Q1 2019

May 07, 2019
SELL
$180.87 - $203.88 $149,036 - $167,997
-824 Reduced 2.54%
31,596 $0
Q4 2018

Feb 08, 2019
BUY
$178.4 - $208.25 $513,435 - $599,343
2,878 Added 9.74%
32,420 $6.31 Million
Q3 2018

Nov 14, 2018
BUY
$185.29 - $208.89 $14,267 - $16,084
77 Added 0.26%
29,542 $0
Q2 2018

Aug 06, 2018
BUY
$166.05 - $186.51 $204,407 - $229,593
1,231 Added 4.36%
29,465 $0
Q1 2018

May 08, 2018
SELL
$169.43 - $198.0 $5,252 - $6,138
-31 Reduced 0.11%
28,234 $0
Q4 2017

Feb 05, 2018
BUY
$168.79 - $188.59 $8,608 - $9,618
51 Added 0.18%
28,265 $0
Q3 2017

Nov 06, 2017
BUY
$167.29 - $191.0 $4.72 Million - $5.39 Million
28,214
28,214 $0

Others Institutions Holding AMGN

# of Institutions
3,123
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Adell Harriman & Carpenter Inc Portfolio

Follow Adell Harriman & Carpenter Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adell Harriman & Carpenter Inc, based on Form 13F filings with the SEC.

News

Stay updated on Adell Harriman & Carpenter Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email